RxDoctor Payments Data

Dennis Newberry, MD

Family Medicine · Henderson, KYNPI 1366437097

Payments from drug & device makers

$1,763in general payments, 2019–2025

Across 110 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$337
  • AbbVie$204
  • Amgen$146
  • Boehringer Ingelheim$131
  • Lilly USA, LLC$126
  • Novo Nordisk$97
  • plus $721 from 19 others

What the payments were for

  • Food & beverage$1,763100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,763 in reported general payments places this provider in the 65th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$134,890
Medicare patients
218
Services billed
1,394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide59$61,305
JanuviaSitagliptin Phosphate64$55,788
EliquisApixaban75$53,309
JardianceEmpagliflozin55$51,629
OzempicSemaglutide40$40,102
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$20,565
FarxigaDapagliflozin Propanediol23$18,789
XareltoRivaroxaban11$14,226
LinzessLinaclotide22$12,585
Spiriva RespimatTiotropium Bromide12$6,216
Lantus SolostarInsulin Glargine,hum.Rec.Anlog52$5,548
Celecoxib14$3,328
Baclofen55$2,623
Levothyroxine Sodium180$1,798
SynthroidLevothyroxine Sodium31$1,761

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$126$61,30559 claims
Boehringer IngelheimJardiance, Spiriva Respimat$131$57,84567 claims
PfizerEliquis$78$53,30975 claims
Novo NordiskOzempic$97$40,10240 claims
GSKTrelegy Ellipta$76$20,56528 claims
AstraZenecaFarxiga$41$18,78923 claims
AbbVieLinzess, Synthroid$204$14,34653 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Henderson

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →